Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Cost Per Daly Averted in Low, Middle- and High-Income Countries: Evidence From the Global Burden of Disease Study to Estimate the Cost-Effectiveness Thresholds
Azin Nahvijou
Azin Nahvijou

Associate Professor of Healthcare Services Management

Cancer Research Center

Tehran University of Medical Sciences

All Documents
1. Assessing Women's Preference and Willingness to Pay for Breast Cancer Screening: A Discrete Choice Experiment Approach, Value in Health Regional Issues (2025)
2. Changes in Employment Status and Income and Workplace Organizational Support Among Cancer Survivors: A Descriptive Study in Iran, Journal of Cancer Policy (2025)
3. Evaluating the Breast Cancer Quality of Care Indicators in Iran; Multicenter Study, BMC Cancer (2025)
4. Challenges and Benefits of Telepathology in Education: Lessons Learned From Covid-19—A Systematic Review, Journal of Public Health (United Kingdom) (2024)
5. Determining the Content of a Melanoma Prevention and Care Mobile Application for Melanoma Patients: A Survey Study, Asian Pacific Journal of Cancer Prevention (2024)
6. Development of a Gastric Cancer Risk Calculator for Questionnaire-Based Surveillance of Iranian Dyspeptic Patients, BMC Gastroenterology (2024)
7. Finding the Psa-Based Screening Stopping Age Using Prostate Cancer Risk, Cancer Treatment and Research Communications (2024)
8. Hospital and Post-Discharge Mortality in Covid-19 Patients With a Preexisting Cancer Diagnosis in Iran, BMC Cancer (2024)
9. Neoadjuvant Chemotherapy in Patients With Her2-Negative Breast Cancer: A Report From Clinical Breast Cancer Registry of Iran, Archives of Iranian medicine (2024)
10. Survey of Awareness and Beliefs About Cancer (Abc) in Tehran Province, Iran, BMC Cancer (2024)
11. Survey of Awareness and Beliefs About Cancer (Abc) in Tehran Province, Iran, BMC Cancer (2024)
12. Classification of Potential Breast/Colorectal Cancer Cases Using Machine Learning Methods, International Journal of Cancer Management (2023)
13. Clinical Breast Cancer Registry of Ir. Iran (Cbcr-Ir): Study Protocol and First Results, Archives of Iranian Medicine (2023)
14. Clinical Breast Cancer Registry of Ir. Iran (Cbcr-Ir): Study Protocol and First Results, Archives of Iranian Medicine (2023)
15. Feasibility of Measuring Comorbidity Indices Based on Clinical Breast Cancer Records; [Faisabilite De La Mesure Des Indices De Comorbidite a Partir Des Dossiers Cliniques Sur Le Cancer Du Sein En Republique Islamique D’Iran], Eastern Mediterranean Health Journal (2023)
16. Machine Learning-Based Mortality Prediction Models for Smoker Covid-19 Patients, BMC Medical Informatics and Decision Making (2023)
17. Optimal Age to Stop Prostate Cancer Screening and Early Detection, Journal of Cancer Policy (2023)
18. Population Attributable Proportion and Number of Cancer Cases Attributed to Potentially Modifiable Risk Factors in Iran in 2020, International Journal of Cancer (2023)
19. Regional Disparities in Cancer Survival in Iran: Insight From a National Surveillance of Cancer Survival in Iran (Irancansurv), Cancer Epidemiology (2023)
20. Regional Disparities in Cancer Survival in Iran: Insight From a National Surveillance of Cancer Survival in Iran (Irancansurv), Cancer Epidemiology (2023)
21. Triple a (Aaa): A Tool to Analyze Scientific Literature Metadata With Complex Network Parameters, 2023 9th International Conference on Web Research# ICWR 2023 (2023)
22. Unraveling Complex Relationships Between Covid-19 Risk Factors Using Machine Learning Based Models for Predicting Mortality of Hospitalized Patients and Identification of High-Risk Group: A Large Retrospective Study, Frontiers in Medicine (2023)
23. Use of Sentiment Analysis for Capturing Hospitalized Cancer Patients' Experience From Free-Text Comments in the Persian Language, BMC Medical Informatics and Decision Making (2023)
24. Using Electronic Health Record System to Establish a National Patient's Registry : Lessons Learned From the Cancer Registry in Iran, International Journal of Medical Informatics (2023)
25. What Do We Learn From a Breast Cancer Awareness Campaign in a Developing Country? a Cross-Sectional Study, Archives of Breast Cancer (2023)
26. A Cost-Effectiveness Modeling Study of Treatment Interventions for Stage I to Iii Esophageal Squamous Cell Carcinoma, Cost Effectiveness and Resource Allocation (2022)
27. Cost–Benefit Analysis of Human Papillomavirus Vaccine in Iran, Journal of Prevention (2022)
28. Determination of a Cost-Effectiveness Threshold for Cancer Interventions in Iran, Frontiers in Oncology (2022)
29. Economic Burden of Gynecological Cancers in Iran, Value in Health Regional Issues (2022)
30. National Surveillance of Cancer Survival in Iran (Irancansurv): Analysis of Data of 15 Cancer Sites From Nine Population-Based Cancer Registries, International Journal of Cancer (2022)
31. National Surveillance of Cancer Survival in Iran (Irancansurv): Analysis of Data of 15 Cancer Sites From Nine Population-Based Cancer Registries, International Journal of Cancer (2022)
32. Population-Based Cancer Survival in the Golestan Province in the Northeastern Part of Iran 2007–2012, Cancer Epidemiology (2022)
33. Smartphone-Based Application for Self-Management of Patients With Colorectal Cancer: Development and Usability Evaluation, Supportive Care in Cancer (2022)
34. The Economic Burden of Esophageal Cancer in Iran, Indian Journal of Cancer (2022)
35. The Lost Productivity Cost of Premature Mortality Owing to Cancers in Iran: Evidence From the Globocan 2012 to 2018 Estimates, Value in Health Regional Issues (2022)
36. Correction To: Psychometric Properties of the Sf-6Dv2 in an Iranian Breast Cancer Population (Breast Cancer, (2021), 28, 4, (937-943), 10.1007/S12282-021-01230-3), Breast Cancer (2021)
37. Cost Per Daly Averted in Low, Middle- and High-Income Countries: Evidence From the Global Burden of Disease Study to Estimate the Cost-Effectiveness Thresholds, Cost Effectiveness and Resource Allocation (2021)
38. Disability-Adjusted Life Years (Daly) for Cancers in Iran, 1990 to 2016: Review of Findings From the Global Burden of Disease Study, Iranian Journal of Public Health (2021)
39. Mapping Qlq-C30 Onto Eq-5D-5L and Sf-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country, Value in Health Regional Issues (2021)
40. Mapping the Cancer-Specific Fact-B Onto the Generic Sf-6Dv2, Breast Cancer (2021)
41. Mothers’ Preferences and Willingness-To-Pay for Human Papillomavirus Vaccines in Iran: A Discrete Choice Experiment Study, Preventive Medicine Reports (2021)
42. Psychometric Properties of the Sf-6Dv2 in an Iranian Breast Cancer Population, Breast Cancer (2021)
43. Requirements of Self-Management Applications for Patients With Colorectal Cancer; [الزامات برنامه های کاربردی خودمدیریتی بیماران مبتلابه سرطان روده بزرگ], Journal of Health Administration (2021)
44. A Conceptual Model of an Oncology Information System, Cancer Management and Research (2020)
45. A Decision Support System for Mammography Reports Interpretation, Health Information Science and Systems (2020)
46. Automated Misspelling Detection and Correction in Persian Clinical Text, Journal of Digital Imaging (2020)
47. Clinical Characteristics and Outcomes of 905 Covid-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran, Archives of Iranian Medicine (2020)
48. Comparing the Performance of the Eq-5D-5L With Two Versions of the Sf-6Dv2 in Patients With Breast Cancer, Health Services and Outcomes Research Methodology (2020)
49. Information Needs of Women With Breast Cancer: A Review of the Literature, Frontiers in Health Informatics (2020)
50. Mapping Disparities in Education Across Low- and Middle-Income Countries, Nature (2020)
51. Mapping Eortc-Qlq-C30 and Qlq-Cr29 Onto Eq-5D-5L in Colorectal Cancer Patients, Journal of Gastrointestinal Cancer (2020)
52. The Global, Regional, and National Burden of Stomach Cancer in 195 Countries, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
53. Economic Evaluation of Treatments for Patients With Esophageal Cancer: A Systematic Review, International Journal of Cancer Management (2019)
54. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
55. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
56. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study, JAMA Oncology (2019)
57. Mapping 123 Million Neonatal, Infant and Child Deaths Between 2000 and 2017, Nature (2019)
58. Mapping 123 Million Neonatal, Infant and Child Deaths Between 2000 and 2017, Nature (2019)
59. Mapping the Cancer-Specific Qlq-C30 Onto the Generic Eq-5D-5L and Sf-6D in Colorectal Cancer Patients, Expert Review of Pharmacoeconomics and Outcomes Research (2019)
60. Oncology Information System: A Qualitative Study of Users' Requirements, Asian Pacific Journal of Cancer Prevention (2019)
61. The Global, Regional, and National Burden of Colorectal Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)
62. Application of E75 Peptide Vaccine in Breast Cancer Patients: A Systematic Review and Meta-Analysis, European Journal of Pharmacology (2018)
63. Cancer Incidence in the East Azerbaijan Province of Iran in 2015-2016: Results of a Population-Based Cancer Registry, BMC Public Health (2018)
64. Development of a Tool for Comprehensive Evaluation of Population-Based Cancer Registries, International Journal of Medical Informatics (2018)
65. Development of a Tool for Comprehensive Evaluation of Population-Based Cancer Registries, International Journal of Medical Informatics (2018)
66. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
67. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
68. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
69. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
70. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
71. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
72. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
73. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
74. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
75. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
76. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
77. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
78. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
79. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
80. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
81. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
82. The Economic Burden of Oral Cancer in Iran, PLoS ONE (2018)
83. Economic Burden of Colorectal Cancer in Iran in 2012, Medical Journal of the Islamic Republic of Iran (2017)
84. Serum Antibodies Against Helicobacter Pylori Neutrophil Activating Protein in Carriers of Il-4 C-590T Genetic Polymorphism Amplify the Risk of Gastritis and Gastric Cancer, Iranian Biomedical Journal (2017)
85. Systematic Review of Hospital Based Cancer Registries (Hbcrs): Necessary Tool to Improve Quality of Care in Cancer Patients, Asian Pacific Journal of Cancer Prevention (2017)
86. Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country With a Low Incidence Rate of Cervical Cancer, PLoS ONE (2016)
87. Priority Setting for Improvement of Cervical Cancer Prevention in Iran, International Journal of Health Policy and Management (2016)
88. Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter Pylori Sero-Status and Serum Pepsinogen Levels, Iranian Biomedical Journal (2015)
89. Relationship Between Spiritual Health and Quality of Life in Patients With Cancer, Asian Pacific Journal of Cancer Prevention (2015)
90. The Economic Burden of Breast Cancer in Iran, Iranian Journal of Public Health (2015)